Name: Lhrh and Its Analogs: Contraceptive and Therapeutic Applications Part 2 (en Inglés)
Price: 266.97 PEN
Availability: InStock
Author: Vickery, B. H. ; Nestor, J. J.
ISBN: 9789401079495

portada Lhrh and Its Analogs: Contraceptive and Therapeutic Applications Part 2 (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Vickery, B. H. ; Nestor, J. J.

Idioma

Inglés

N° páginas

614

Encuadernación

Tapa Blanda

Dimensiones

24.4 x 17.0 x 3.3 cm

Peso

1.01 kg.

ISBN13

9789401079495

Categorías

Fisiologiía
Ginecología y obstetricia
Jardinería

Lhrh and Its Analogs: Contraceptive and Therapeutic Applications Part 2 (en Inglés)

Vickery, B. H. ; Nestor, J. J. (Autor) · Springer · Tapa Blanda

Libro Nuevo

S/ 266,97

S/ 533,94

Ahorras: S/ 266,97

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 30 de Julio y el Martes 13 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Lhrh and Its Analogs: Contraceptive and Therapeutic Applications Part 2 (en Inglés)"

Since the discovery of LHRH in 1971, research into the physiology and therapeutics of this compound can be divided into three dis- tinctly different phases. In the first phase, attention was paid chiefly to the natural sequence hormone; efforts were channeled to explore its diagnostic use; and nearly all the clinical investigations were coordinated by a single pharmaceutical company. The successes in this area were quite limited and the interest in the promise of this agent as a diagnostic test has long since waned. This phase of research con- sumed roughly the first seven years of clinical testing after the isolation and characterization of the compound by the two groups involved in the Nobel effort. With the appearance of long-acting LHRH agonists, the second phase of research on LHRH began in the late '70's. LHRH agonists were the only compounds available during this period of research and paradoxical desensitization was the predominant therapeutic basis for the discoveries. An ever-widening number of therapeutic applications using this approach were unearthed. A second theme which emerged during this second 5-7 year period was that the pulsatile administration of the natural sequence LHRH could be used to treat LHRH deficiency in men and women.